EIA
Edgemoor Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.9M | Sell |
56,024
-772
| -1% | -$344K | 2.15% | 13 |
|
|
2025
Q1 | $27.5M | Sell |
56,796
-301
| -0.5% | -$146K | 2.53% | 10 |
|
|
2024
Q4 | $23M | Buy |
57,097
+92
| +0.2% | +$37K | 2.03% | 14 |
|
|
2024
Q3 | $26.5M | Buy |
57,005
+123
| +0.2% | +$57.2K | 2.31% | 13 |
|
|
2024
Q2 | $26.7M | Buy |
56,882
+350
| +0.6% | +$164K | 2.48% | 13 |
|
|
2024
Q1 | $23.6M | Buy |
56,532
+150
| +0.3% | +$62.7K | 2.23% | 13 |
|
|
2023
Q4 | $22.9M | Buy |
56,382
+544
| +1% | +$221K | 2.4% | 10 |
|
|
2023
Q3 | $19.4M | Buy |
55,838
+254
| +0.5% | +$88.3K | 2.3% | 11 |
|
|
2023
Q2 | $19.6M | Sell |
55,584
-279
| -0.5% | -$98.2K | 2.21% | 10 |
|
|
2023
Q1 | $17.6M | Buy |
55,863
+343
| +0.6% | +$108K | 2.14% | 10 |
|
|
2022
Q4 | $16M | Sell |
55,520
-310
| -0.6% | -$89.5K | 2.01% | 10 |
|
|
2022
Q3 | $16.2M | Buy |
55,830
+799
| +1% | +$231K | 2.15% | 10 |
|
|
2022
Q2 | $15.5M | Sell |
55,031
-122
| -0.2% | -$34.4K | 1.95% | 12 |
|
|
2022
Q1 | $14.4M | Buy |
55,153
+10,825
| +24% | +$2.82M | 1.52% | 15 |
|
|
2021
Q4 | $9.73M | Buy |
44,328
+9,654
| +28% | +$2.12M | 1% | 35 |
|
|
2021
Q3 | $6.29M | Buy |
+34,674
| New | +$6.29M | 0.72% | 43 |
|